Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

Cosmetics FDA Regulatory Lawyer Serving Brickell

Brickell — Miami’s financial district, home to the banks, trade finance desks and regional headquarters that fund and direct hemispheric trade — keeps a cosmetics FDA regulatory lawyer busier than almost anywhere in America. Brickell is the financial capital of Latin American trade — the banks that finance Miami’s imports, the regional headquarters that direct them, and the executives who make product and market-entry decisions for the hemisphere all sit within a few blocks. Garg Law’s Miami office is here, at 1221 Brickell Avenue, in the middle of that corridor. The companies steering FDA-regulated product lines from Brickell towers need regulatory answers at deal speed — and the office handling them is on the same street.

Quick answer

MoCRA rebuilt cosmetics regulation: facility registration, product listing, safety substantiation and adverse-event obligations now apply to an industry that spent decades nearly unregulated. Add the old traps — drug claims, color additives, labeling — and cosmetics brands and importers need real regulatory infrastructure for the first time.

Why this matters now

Cosmetics import volume through Miami is enormous and FDA’s screening of it is no longer light-touch: unregistered facilities, unlisted products, drug claims and color-additive violations all surface as detentions. MoCRA converted informal industry habits into federal violations — brands running on pre-2023 practices are accumulating exposure.

The rules in plain terms

The Modernization of Cosmetics Regulation Act (MoCRA) is the biggest change to U.S. cosmetics law since 1938. Most cosmetic facilities must register with FDA and renew biennially, products must be listed, brands must maintain safety substantiation, serious adverse events must be reported, and foreign facilities need a U.S. agent. FDA gained records access and mandatory recall authority over cosmetics.

The classification line remains the industry’s oldest trap: a cosmetic “beautifies and cleanses”; the moment claims promise to treat acne, regrow hair, boost collagen production or alter skin structure, the product is a drug — unapproved, and enforceable as such. Miami’s beauty import trade, one of the largest in the country, meets this line at the border where FDA screens labels shipment by shipment.

Underneath sit the classic rules: color additives must be approved for their use (a strict-liability favorite), labeling must follow FDA and FPLA requirements including INCI ingredient declarations, and talc-containing products now face mandated asbestos testing standards.

How the process works

  1. MoCRA compliance build-out: facility registration, product listing, U.S. agent arrangements, renewal calendars
  2. Safety substantiation files — the evidence MoCRA requires brands to hold for every product
  3. Claims and labeling review: the cosmetic/drug line, ingredient declarations, color-additive verification
  4. Import compliance for finished goods and components — entry data, supplier documentation, detention response
  5. Adverse-event procedures and enforcement response, including MoCRA’s new records and recall powers

Serving Brickell from Brickell

The work around Brickell — international banking and trade finance, multinational regional headquarters, consumer brand offices, legal and professional services, import/export holding companies — is FDA-regulated at nearly every turn, and matters here move on Miami’s financial district, home to the banks, trade finance desks and regional headquarters that fund and direct hemispheric trade. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.

Best practices — and common mistakes

  • Assuming cosmetics still need nothing from FDA — MoCRA ended that era
  • Marketing copy that makes drug claims a formulation cannot legally support
  • Using color additives outside their approved uses — strict liability, no intent required
  • Importing for a foreign brand with no U.S. agent and no responsible person designated
  • Holding zero safety substantiation because “nobody ever asked” — MoCRA lets FDA ask

Frequently asked questions

What did MoCRA change for cosmetics companies?

Nearly everything structural: mandatory facility registration and biennial renewal, product listing, safety substantiation requirements, serious adverse-event reporting with records retention, U.S. agents for foreign facilities, and FDA mandatory recall authority. Cosmetics went from barely regulated to a registered, inspectable industry.

When does a cosmetic become a drug in FDA’s eyes?

When its intended use — shown by claims on labels, websites and ads — goes beyond cleansing and beautifying into treating conditions or affecting the body’s structure or function. “Reduces the appearance of wrinkles” is cosmetic; “rebuilds collagen” is a drug claim. The wording is the whole game.

Do foreign cosmetics brands selling into the U.S. need registration?

Their manufacturing facilities generally must register (with a U.S. agent), their products must be listed, and a responsible person must handle listings and adverse events. Importers should verify all of it — unregistered-facility shipments are detention candidates.

Why would a cosmetics shipment be detained at the border?

The recurring bases: drug claims on labels, unapproved color additives, missing facility registration, adulteration or microbial concerns, and import-alert matches. Miami sees heavy cosmetics screening; label review before shipping prevents most of it.

What safety substantiation does MoCRA require?

Adequate evidence supporting the safety of each cosmetic product — testing, studies or other reliable data held by the responsible person. There is no filing; the obligation is to possess it and produce it when FDA asks. Brands should build these files product by product, starting with the biggest sellers.

Explore related pages

Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.